Keyword: drug testing

  • Horsemen: Harsh Penalties for Dermorphin

    The National HBPA and its affiliates said they have "zero tolerance" for trainers who use illegal Class 1 and Class 2 substances in racehorses in the wake of about 30 positives for Dermorphin in the Southwest.

  • Salix

    KY Salix Meeting: More Questions Than Answers

    During an oddly lopsided meeting on a proposal to phase-out use of furosemide on race day in listed and graded stakes in Kentucky, proponents of the therapeutic anti-bleeding medication made their case. But it may not matter.

  • Minnesota Makes Equine Drug-Testing Changes

    A new law that allows for an expansion of racetrack card clubs in Minnesota also permits the Minnesota Racing Commission to set threshold testing levels for therapeutic medications used in racehorses.

  • Left to right: Nick Nicholson, Matt Iuliano, and Alan Foreman at the panel discussion on race-day medication, part of the first day of the University of Kentucky Equine Law Conference.

    Race-Day Drugs, Regulation Discussed by Panel

    The racing industry is closer to uniformity in drug regulations and penalties than many admit, but agreement on race-day anti-bleeding drugs in a "toxic" environment will require some heavy lifting, officials said May 2.

  • PA Horsemen Call for State-Level Meetings

    A coalition of Pennsylvania horsemen is seeking a series of "state-level" meetings of all stakeholders in horse racing to examine ways to improve the health and safety of equine and human participants.

  • Udall Says 'Corruption' in Racing Alarming

    A member of Congress who in 2011 co-sponsored federal legislation that would regulate safety and integrity in horse racing has renewed his call in the wake of a March 25 report in the New York Times.

  • Committee Will Examine Gural Slots Proposal

    The United States Trotting Association has formed a committee to examine a proposal to use a small percentage of gaming revenue to support marketing and enhanced equine drug testing, but stopped short of endorsing the plan.

  • Trainer John Shirreffs

    Shirreffs to Chair CHRB Advisory Panel

    Trainer John Shirreffs has been named to chair a newly created medication advisory panel for the California Horse Racing Board to provide consultation with the agency's medication and track safety committee.

  • Approval of Bute Rule Slowed in Louisiana

    A Louisiana Senate committee rejected an emergency rule approved by the Louisiana State Racing Commission to lower the testing threshold level for phenylbutazone from 5 micrograms per milliliter to 2 micrograms.

  • Officials Say Report Dispels Drug Criticism

    Racing industry officials said a report that shows 99.5% of biological samples taken from racehorses and tested by laboratories in 2010 were "clean" dispels claims that horse racing is drug-ridden.

  • Waterman Named Arizona Racing Adviser

    Dr. Scot Waterman, most recently executive director of the Racing Medication and Testing Consortium, has been hired as the first animal medication and welfare adviser for the Arizona Department of Racing.

  • RMTC: Tighten Salix Rules, Ban Adjunct Drugs

    An industry consortium supports administration of Salix by regulatory veterinarians only and a ban on adjunct bleeder drugs, but will continue to study a pilot program proposal to ban the use of race-day Salix in 2-year-olds.

  • Florida Salix Plan Called 'Terrible Mistake'

    Gulfstream Park has not set a timetable for possible future contact with Florida racing regulators on chairman Frank Stronach's goal of phasing out use of legal race-day medications such as the anti-bleeding drug Salix.

  • CANTER: Federal Drug Bill Needs Fine-Tuning

    CANTER, a major placement program for retired Thoroughbred racehorses, said it supports in concept federal legislation calling for a ban on performance-enhancing drugs in racing but believes the language may be too broad.

  • AAEP Urges Caution on Federal Drug Bill

    The American Association of Equine Practitioners has expressed concern with "very broad language" in federal legislation geared toward use of performance-enhancing drugs in racehorses.

  • Officials Confirm International Drug Summit

    As expected the Racing Medication and Testing Consortium board of directors said April 20 it will join the National Thoroughbred Racing Association and American Association of Equine Practitioners in organizing a drug summit.

  • International Drug Summit Said to Be Planned

    Industry organizations including the National Thoroughbred Racing Association will propose an international summit on equine medication this year in the wake of calls for the race-day ban of anti-bleeding drugs.

  • Alan Foreman

    Horsemen: Put Brakes on Race-Day Salix Ban

    The largest horsemen's groups in the country said they don't support a call by the Association of Racing Commissioners International for a five-year phase-out of race-day anti-bleeding medications.

  • TOBA Latest Group to Support Medication Ban

    The Thoroughbred Owners and Breeders Association said April 14 it supports the recent proposal by the Association of Racing Commissioners International to develop a plan to eliminate the use of race-day medication.

  • Sources: Waterman Leaving Post at RMTC

    Dr. Scot Waterman, executive director of the Racing Medication and Testing Consortium for almost 10 years, is leaving the post at the end of April, according to multiple industry sources.

  • KTA Supports, NTRA Discusses, Drug Phase-Out

    The Kentucky Thoroughbred Association and Kentucky Thoroughbred Owners and Breeders, which operate as one entity, issued a statement April 12 saying it supports a call by RCI to phase out race-day medication.

  • Montaineer Race Track

    New WV Rules of Racing Take Effect July 10

    An overhaul of the West Virginia rules of racing, including revisions in the area of equine medication and penalties, has passed the state legislature. The document was filed April 11 with the Secretary of State.

  • RCI: Phase Out Use of Drugs in Five Years

    In an announcement that could meet with disagreement with some horsemen's groups and perhaps others, the Association of Racing Commissioners International has called for a five-year phase-out of equine medication in racing.

  • Life At Ten Probe Ongoing; Drug Tests Done

    The Kentucky Horse Racing Commission Feb. 9 offered no timeline for the ongoing probe into Life At Ten's performance in the 2010 Breeders' Cup Ladies' Classic, though there was public acknowledgment of drug testing.

  • RCI Board Votes to Lower Bute Threshold

    The Association of Racing Commissioners International board of directors voted Oct. 22 to lower the threshold level for phenylbutazone from five micrograms per milliliter of plasma or serum to two.